Podcasts about Kerin

In this episode, Trish Kerin and Traci Purdum explore process hazard analysis revalidations and how to make them more effective. Kerin explains the difference between redoing a PHA and revalidating existing assessments, introducing the Delta HAZOP methodology that focuses on creeping change in facilities. She discusses triggers for revalidation, from legislative requirements to significant operational changes, and emphasizes the importance of selecting the right team and methodology. Kerin highlights how AI and machine learning can help gather data and identify trends, while stressing that human expertise remains essential. The key takeaway: approach revalidations with rigor and discipline, not as tick-box exercises, to truly identify hazards and manage risk effectively.

Endometriosis is far more than “bad periods.” It is a complex, inflammatory, hormone-driven condition that can affect the entire body. In this episode, I'm joined by Dr. Iris Kerin Orbuch, a respected expert in endometriosis and pelvic pain, for a deep, honest conversation about what endometriosis really is and why it is still so widely misunderstood in mainstream medicine. We covered SO much in this shorter episode - prepare to learn; What endometriosis is and how it develops Common and overlooked symptoms of endometriosis What clinicians should look for when diagnosing endometriosis The role of estrogen dominance in endometriosis Inflammation and its connection to chronic pelvic pain The links between endometriosis, autoimmune disease, and gut health Why it can take years, or even decades, to receive a diagnosis How endometrial tissue can appear outside the pelvis and throughout the body - including in the nose and brain The impact of endometriosis on a woman's quality of life, mental health, fertility, and relationships Whether endometriosis appears to be familial or genetic Adenomyosis and how it overlaps with endometriosis We also explore treatment options, including: Laparoscopic surgery and advanced endometriosis treatment Excision vs ablation and why the difference matters Birth control pills and IUDs Concerns around estrogen stimulation Dr. Iris Kerin Orbuch, author of Beating Endo How to Reclaim Your Life From Endometriosis, is the Founder of Iris Wings Sanctuary for Endometriosis Surgery & Wellness in Los Angeles. Dr. Iris Kerin Orbuchs' practice is limited to Laparoscopic and Robotic Gynecologic Surgery, and is primarily a referral practice. Her training, under the guidance of Dr. C.Y. Liu and Dr. Harry Reich - both pioneers in the field of advanced laparoscopic surgery — allows Dr. Kerin Orbuch to be one of a handful of physicians across the country trained to perform advanced minimally invasive procedures. You can follow Dr Kernin Orbuch and find out more about her work here; Website - https://www.lagyndr.com/ Instagram 1 - / dririskerinorbuch Instagram 2 - / iriswings Beating Endo book - https://a.co/d/5pwEoM6

Host Dr. Davide Soldato and guests Dr. Kerin Adelson and Dr. Maureen Canavan discuss JCO article "Association Between Systemic Anticancer Therapy Administration Near the End of Life with Health Care and Hospice Utilization in Older Adults: A SEER Medicare Analysis of End-of-Life Care Quality," highlighting adverse outcomes for patients who receive any type of systemic anticancer therapy(SACT) at EOL (end of life) and the need for better communication between oncologists and patients regarding expected risk and benefits of such treatments to properly align goals-of-care. TRANSCRIPT Dr. Davide Soldato: Hello and welcome to JCO After Hours, the podcast where we sit down with authors from some of the latest articles published in the Journal of Clinical Oncology. I am your host, Dr. Davide Soldato, medical oncologist at Ospedale San Martino in Genoa, Italy. Today, we are joined by JCO authors Dr. Maureen Canavan, epidemiologist and associate research scientist at Yale Cancer Outcomes, Public Policy and Effectiveness Research Center; and by Dr. Kerin Adelson, Chief Quality and Value Officer, medical oncologist, and clinical researcher on health services and clinical care delivery at MD Anderson Cancer Center. In the manuscript "Association Between Systemic Anticancer Therapy Administration Near the End of Life With Health Care and Hospice Utilization in Older Adults: A SEER-Medicare Analysis of End-of-Life Care Quality." that you recently published in the JCO, you performed an analysis that included more than 30,000 older adults in the SEER-Medicare database, and you observed that 7.6% of these patients received any systemic anticancer medication within 30 days of death. So, I wanted you to explain why you thought that this was a priority right now, and whether there was any previous data that was published in the literature, and if you think that there was any significant gap in the literature that led you to the research you just published. Dr. Kerin Adelson: We have published a series of articles looking at real-world trends  in patterns of care, particularly related to systemic anticancer therapy at the end of life. This has been gaining increasing focus in recent years because of the understanding that when patients stay on systemic anticancer therapy, that is often a surrogate for a lack of goal-concordant care. So, patients who continue to receive systemic therapy have worse quality of life, are more likely generally to have a medicalized death, and less likely to use hospice. And what our prior work has shown is that more and more we are seeing patients using immunotherapies and targeted therapies towards the end of life. No prior work had really comprehensively examined whether these novel therapies were associated with those same patterns of care increases in acute care utilization and decreases in hospice. Dr. Davide Soldato: So basically, the data that we had up until that point was mostly with cytotoxic chemotherapy, and the emergence of this new treatment, which frequently are thought to be less toxic and so less problematic also in the end of life, led to this research. Is that correct? Dr. Kerin Adelson: Correct. Dr. Maureen Canavan: I would also build on that. I think that as the landscape of cancer care changes, it is important to really understand the availability of treatments, but then also, as Kerin noted, it is important to focus on goal-concordant care. We have established literature, studies we have done and some other studies that have looked at cytotoxic chemotherapy, but with the emergence of these targeted therapies, we really did not know a few things. We did not know the rates of utilization in a large national population, and how that was associated with these elements of medicalized death like ED use, hospitalizations, acute care use. So this was really a question that we had going into it. How can we expand the knowledge base so that both patients and providers can be more cognizant when thinking about goals of care conversations and ensuring that that is in place? Dr. Kerin Adelson: And our work has kind of evolved to answer some critical questions. So, one of our early papers looked at different rates of systemic anticancer therapy at the end of life, and that is where we showed that we were seeing a lot more immunotherapy and targeted therapy. And then we asked the question, well, oncologists generally when they give these treatments, they are hoping that those treatments are going to work and help the patients live longer. So we did another paper where we actually looked at practices who were more aggressive near the end of life and whether they had better overall survival than practices that were less aggressive, accounting for the fact that there could be populations of patients who benefited. And in fact, we showed there was no survival difference. So then this paper sort of answered the question: Well, if it is not having benefit, is this treatment actually doing harm? And this study gets at that question: What are the harms of continuing patients on therapy past the point of benefit? Dr. Maureen Canavan: And I think building off of that, the use of the SEER-Medicare database is a quite robust database. So in this, we have very specific data we can track. We can track the exact type of treatment they had, you know, was it a targeted therapy? Was it immunotherapy? So looking at those subclasses of therapy. We were also able to directly link it within that time frame to the acute care utilization, a limitation that we had in some of our previous work that that data was not always available. So it is more focused in the sense that we were looking at older adults, so patients 66 years of age and older, but we were able to get those individual metrics. So to Kerin's point, we did not see the survival benefit. What do we see then for these medicalized death elements? So the higher rates of all of them across the board. Dr. Davide Soldato: So coming back to the cohort and to the data that you utilized, Dr. Canavan mentioned the use of the SEER system to analyze these data. You already mentioned that you included mostly older adults, so those aged 66 and more. And also there was a little bit of restriction regarding the fact that the patient needed to be covered by Medicare in the last year of death concerning Part A and Part B, and the last 30 days from death concerning Part D. So I just wanted to ask a little bit of a question regarding these findings and whether you think that we also need additional work, especially in the younger population because I think it is something that all of us who work in oncology have seen. The aggressiveness, and this is also something that you showed in your data, tends to increase as the age of the patient tends to decrease. So we tend to be more aggressive towards younger patients. So just a comment on that on the population and generalizability of the findings. Dr. Maureen Canavan: Yeah, I will start with the data question element. Thank you. I think there are a few things to point out for that. So in terms of the restriction to ensure that they had continuous Part D coverage, that was necessary for us to track their oral medication use during that time. So kind of an easy response. The Part A, Part B requirement, it is actually pretty widely used in studies of SEER-Medicare data, and that is you want to establish the patient population, that they are not getting treated with another insurance provider in some way that you are not able to track. So that ensures that we can track not only their systemic anticancer therapy use but also when we are trying to make sure that we are controlling for confounders like chronic conditions and stuff, we are able to track the presence of chronic conditions. So we wanted to make sure we were not biasing the data, so I think that was an important consideration. You do point out very wisely that there are then limitations with the generalizability, and I think we would be lacking if we did not account for that. But I think it is important to establish this baseline relationship association, and then you can step out, we will say, to more diverse populations. So I think we could potentially maybe try to relax the timeline to see if people that might have influx in and out of the Medicare system are still seeing those same rates. I think it is likely they would. But I think to the bigger point that you bring up is that establishing this within the older adults where, you know, we do see as they get older maybe less rates of systemic therapy, extending it to the younger population. There is a challenge with that in that just that data is not available to the robust level that SEER-Medicare is. Both Kerin and I have noted that there is the possibility to look within one specific insurance provider type. Again, recognizing the limitations of the generalizability, but always slowly pushing the needle, finding out more about younger adult populations. And I think this is maybe in an ideal world, but setting the precedent that we really do need to track this on a national scale within younger adults because they do have the need. We do see these higher rates of utilization, and really making sure again with the mindset always of the best interest of patients and the most informative to providers in how we are looking at care. So I think generalizability is definitely a goal. However, there are limitations of the availability of data for younger populations and I think that they are a necessary restraint that all researchers should acknowledge. Dr. Kerin Adelson: Yeah, I think it is important for our audience to understand that health services research and large database research is really limited by what databases are available and what are the characteristics of those databases. So we have done a lot of work in an electronic health record database, and there you can get certain kinds of granularity that you may not be able to get in a payer or a claims-based database. But what you do not get is that comprehensive look at, say, what happens if a patient goes to another practice. Claims-based databases offer you that, but research on US populations is limited by our payment system. So when you look at younger patients, there are so many different insurance companies that when you are trying to get that comprehensive view, it can be hard or very expensive actually. These commercial insurers will sell their data to different databases. So for us, the largest single payer in the United States is the US government, and that is for patients who are over age 65, and that is why you see lots of US-based studies done in the Medicare population. Interestingly, a recent paper by a Canadian group showed very, very similar patterns. It was a significantly smaller study but, right, Canada is a single-payer system and so they were able to really look at all ages, and we did see the same patterns of care in a different payment system. Dr. Davide Soldato: Going back a little bit to the type of treatments that were observed in your manuscript, so we start from a 7.6% of patients who received any type of systemic anticancer therapy within 30 days from death. And when we split the different categories that you analyzed, which I think is a very strong aspect of your manuscript, we see that more or less 50% of the patients received chemotherapy, 20% more or less received immunotherapy, more or less 20% targeted therapy, and then there is a combination of those agents. So just wanted to have a little bit of your opinion compared also to the data that you already published and that you mentioned before. Was this in line with previous data? Was there anything surprising about this? We saw a little bit of a raise in the use of immunotherapy and targeted therapy as you were saying, but still, there is a very high proportion of chemotherapy, 50%. Dr. Kerin Adelson: So I think that really, really reflects the time period in which we studied where immunotherapies were gaining ground. There was tons of excitement and we were seeing this shift. I bet if we do the same study in five years that chemotherapy percent may even go down to half, and we are going to see more and more targeted and immunotherapies, and that is just reflecting the pattern of drug discovery that we are seeing. Dr. Davide Soldato: Coming to the real question that you wanted to answer with this manuscript, so is systemic anticancer therapy associated with worse outcomes in terms of healthcare utilization and use of hospice resources? Was there any hint that for example immunotherapy was related to less of these adverse outcomes? Dr. Kerin Adelson: So I will be honest, I was a little bit surprised that the combination of chemotherapy and immunotherapy was that much more strongly correlated with acute care use at the end of life. You know, I had really thought most likely that what we would see were similar rates. And we did. Each different type of systemic anticancer therapy was associated with significantly higher odds of ending up in the hospital, going to the ICU, dying in the hospital, going to the ED. But that group that got dual therapy was that much higher, you know, over three times the risk. And that surprised me because what it suggested is that there is likely a component of treatment toxicity that is leading to some of the acute care use. It is not simply just a constellation of patients who have not yet transitioned towards hospice or palliative care or end-of-life care who are then more likely to end up in the hospital. But the fact that we see a difference between, say, single-agent immunotherapy and dual combination with chemotherapy does suggest that the treatments are actually contributing to some of what we are seeing. Dr. Davide Soldato: But still, all of the treatments that you evaluated were still associated with higher healthcare utilization. Like there was no signal that, for example, giving immunotherapy at the end of life was not associated with these adverse outcomes. Correct? Dr. Kerin Adelson: Correct. And you will find oncologists out there who will say, actually, these treatments are so good that they might actually lower rates of hospitalization because they keep patients healthy. And certainly, that may be true upstream or earlier in the course of disease, but at the end of life, any form of systemic anticancer therapy is really a surrogate marker for lack of transition towards what is likely appropriate end-of-life therapy. And I just want to point out that time spent in the hospital, going back and forth to invasive procedures, going to the intensive care unit, even going back and forth to an infusion center, that is time that is not spent at home with loved ones for people who have very little time left to live. Dr. Davide Soldato: Thank you very much. That was exactly the point that I wanted you to stress because I think it is really the most important message that we can get as oncologists from this manuscript. Like there is no treatment that is not associated with potentially harming our patient and, as you were saying, taking off time with loved ones in a critical period of the life of these individuals who have been diagnosed and treated for cancer. So, basically what we saw in the paper was a 7.65% utilization of systemic anticancer therapy. And I might imagine that for some oncologists or for some hematologists that might not actually be that much. Like they could potentially say, "Okay, but it is like 7%, it is not that high. I would have expected something higher." So I just wanted a little bit of perspective regarding also quality metrics that we have available for these types of indicators at end-of-life care. What would be the appropriate percentage of people receiving any type of treatment within 30 days from death? Dr. Maureen Canavan: A couple caveats, as a data person I always like to give those. This was among all cancer patients, so not necessarily patients that had been on active treatment. So I think that number was actually quite lower than when we looked in another study about patients that had chemo within the last year, so on, you know, active treatment. So I think that is an element to take into consideration is that those numbers will vary based on who your denominator population is. So that is important to consider. Additionally, the National Quality Forum, they call for reducing rates of systemic therapy at end of life. But I think they, similar to how I would be, are cautious to point out this is the exact number, or it should be zero. Because there are cases where you have to go in line with patient preferences. And if a patient is very adamant that they want to continue treatment, that needs to be a decision that comes between them and their provider. So, you know, the zero, though sounding ideal to us who want to encourage transitions and encourage goals of care conversation is a nice number, it is not a realistic. So, to evade your question completely, I do not think there is a set number. But the goal is to make sure that both patients, providers, everyone is informed and is making the best holistic decision. So there is this natural tendency, I think, to keep fighting both for the patient and the provider to try to beat something, but recognizing the point at which we are beyond a benefit of treatment and what would be most beneficial to the patient in terms of getting back to that idea of, you know, the time with their families and whatnot. So is the number zero? No. Could it probably be lower than we have? I think yes, definitely. Dr. Kerin Adelson: I completely agree with everything Dr. Canavan said. I think one of the other challenges is that this data isn't being tracked and publicly reported across the world. And so what that optimal rate is, is a little unclear. We see different rates also depending on the population included. So one of the things Dr. Canavan said is our database included patients who were likely treated long ago for cancer and cured of their cancer. So they were less likely to die on systemic therapy. But until everybody starts tracking and reporting, it is really hard to know where we are as a country or really as a global population, and then what are the bars that we want to achieve in driving down the rates. I think some data shows that probably something in the range of 10% or below, you know, for patients who have more active cancer is probably where we should be going and driving towards. But until we have more public reporting of these metrics and consistency in how we measure them, it is really hard to come up with a single number. Dr. Davide Soldato: I have the impression that sometimes there is also a little bit of difficulty for the oncologist or the hematologist to really understand who are the patients who are approaching end of life. So there has been some data and you also report some of them in the discussion of the manuscript regarding, for example, prompts inside of the electronic health records or the use of artificial intelligence to try to predict what is the disease course. So just wanted a little bit of perspective if you think that these tools could potentially be helpful and if you think that we will be able at a certain point to implement them in routine clinical care. Dr. Kerin Adelson: I have been working on trying to do this actually at MD Anderson and coming up with a really reliable data tool that will tell us who are the patients who are going to die in short order after receiving systemic anticancer therapy. And it is not that easy, I will say. So, you know, I think we all want this amazing machine learning model that is incredibly reliable. But like any statistical test, there are problems, right? So a very sensitive test that is going to identify high, high risk of dying at the end of life is going to be compromised by false positives. And when an oncologist knows that the test might be a false positive, it becomes very hard for them to take action on it. Similarly, you know, a very, very specific test is going to be compromised by false negatives. So in that case, you could end up having patients who are at risk for dying and still treating them with chemotherapy. And so, you know, I think in the end we need some tools. It will be great if machine learning becomes very reliable and we have the right structured data elements in our electronic health records to give these reliable prediction tools. But I think there are some basic things that we all know, and those are the markers of chronicity of cancer. So patients who have had multiple lines of therapy already, right? Past the point of clinical trial benefit. Patients who have lost significant amounts of weight. Patients who are not getting out of bed and have worse performance status. Patients who are increasingly confused, right? And not mentally engaging the way they did previously. Those markers have been shown in numerous publications by a colleague of mine, David Hui and others, to really be pretty strong predictors, and they resonate with clinicians more than a machine learning score might. You know, I think when clinicians do not understand what the elements in a machine learning tool are, they are less likely to trust it and more likely to say, "Oh, it is a false positive or a false negative." But very few clinicians can argue against the fact that the patient who hasn't gotten out of bed in two weeks is somebody who is less likely to benefit. Dr. Davide Soldato: Dr. Adelson, I would like to close this podcast and I would like to thank you again for joining us today. Dr. Maureen Canavan: Thank you so much. Dr. Kerin Adelson: Thank you so much for having us. Dr. Davide Soldato: Dr. Canavan, Dr. Adelson, we appreciate you sharing more on your JCO article titled "Association Between Systemic Anticancer Therapy Administration Near the End of Life With Health Care and Hospice Utilization in Older Adults: A SEER-Medicare Analysis of End-of-Life Care Quality." If you enjoy our show, please leave us a rating and review and be sure to come back for another episode. You can f ind all ASCO shows at asco.org/podcast. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.    Disclosures Kerin AdelsonStock and Other Ownership Interests: Carrum Health Consulting or Advisory Role: Abbvie, Quantum Health, Gilead SciencesPatents, Royalties, Other Intellectual Property: Genentech Other Relationship: Genentech/Roche Employment: Emilio Health/Brightline Health(An Immediate Family Member) Stock and Other Ownership Interests: Emilio Health/Brightline Health, Lyra Health (An Immediate Family Member)

Send us a textIn this episode of Your Child Is Normal, Dr. Jessica Hochman sits down with endometriosis specialist Dr. Iris Kerin Orbuch, author of Beating Endo: How to Reclaim Your Life from Endometriosis and a key medical voice in the films Endo What? and Below the Belt.Dr. Orbuch explains what endometriosis is, why it's so common yet underdiagnosed, and how it often first shows up in teens—not only as painful periods, but often as chronic gut issues, fatigue, and “IBS” that never fully resolves. She shares how she evaluates patients, why excision surgery is considered the gold standard, and how she combines surgery with pelvic floor physical therapy, gut work, mindfulness, and trauma-informed care to help patients truly heal.Also discussed:The red flags that period pain that starts interfering with school, sports, and social life is not normal.How endometriosis can show up years before a teen ever gets her first period.Why birth control can help symptoms but acts as a Band-Aid, not a cure, and doesn't stop disease progression.How endometriosis is linked to infertility, and why diagnosing and treating it early matters.Practical next steps for parents: when to suspect endo, how to talk to your pediatrician or OB-GYN, and what kind of specialist to look for.This episode is meant to give parents a clearer sense of when to worry, when to push for more answers, and how to support teens who might be living with endometriosis.Connect with Dr. Iris Kerin OrbuchWebsite: https://www.lagyndr.comIris Wings – Sanctuary for Endometriosis Surgery & Wellness 9001 Wilshire Blvd, Suite 207Beverly Hills, CA 90211 Phone: (310) 651-7333 Follow her on Instagram:@dririskerinorbuch@iriswings Buy her Book: Beating Endo: How to Reclaim Your Life from EndometriosisYour Child is Normal is the trusted podcast for parents, pediatricians, and child health experts who want smart, nuanced conversations about raising healthy, resilient kids. Hosted by Dr. Jessica Hochman — a board-certified practicing pediatrician — the show combines evidence-based medicine, expert interviews, and real-world parenting advice to help listeners navigate everything from sleep struggles to mental health, nutrition, screen time, and more. Follow Dr Jessica Hochman:Instagram: @AskDrJessica and Tiktok @askdrjessicaYouTube channel: Ask Dr Jessica If you are interested in placing an ad on Your Child Is Normal click here or fill out our interest form.-For a plant-based, USDA Organic certified vitamin supplement, check out : Llama Naturals Vitamin and use discount code: DRJESSICA20-To test your child's microbiome and get recommendations, check out: Tiny Health using code: DRJESSICA The information presented in Ask Dr Jessica is for general educational purposes only. She does not diagnose medical conditi...

Sonce na Zemljo pošlje vsakodnevno dovolj energije, da bi z njo lahko pokrili vse potrebe človeštva po njej in še mnogo več. A kljub temu je danes povsem očitno, da se tovrstna 'energetska enačba' - vsaj za zdaj - nikakor ne izide v obojestransko zadovoljstvo človeštva in planeta.Morda pa bi se lahko naslonili na že stoletje in več stare ideje Hermana Potočnika Noordunga in Nikole Tesle ter prestregli potrebno energijo, ki prihaja s Sonca, kar v Zemljini orbiti? Nad atmosfero je fotonov mnogo več kot na površju, oblakov tam ni in paneli bi načeloma lahko zbirali energijo 24 ur na dan ter jo pošiljali na izbrano lokacijo na Zemlji. O tem resno razmišljajo pri Nasi in v drugih vesoljskih agencijah, vse več je tudi ambicioznih podjetij, ki stavijo na to, da so prav orbitalne elektrarne tisti pravi odgovor na dilemo brezogljične prihodnosti skupaj z obiljem električne energije.Kje je danes na tem področju meja med fantastiko in realno možnim, v Intelekti razmišljajo dr. Uroš Kerin, direktor Elektroinštituta Milana Vidmarja, izr. prof. dr. Marko Jošt s Fakultete za elektrotehniko Univerze v Ljubljani ter prof. dr. Mihael Sekavčnik s Fakultete za strojništvo Univerze v Ljubljani.Foto: umetniška upodobitev prenosa energije z orbite na Zemljo, projekt Solaris, ESA

Earn 0.75 CPD here: https://quiz.ensombl.com/ENSO-25111900-21450001 0.25 Tax (Financial) Advice 0.50 Technical Competence Joel is an Associate Director at Ally Wealth Management. He and James discuss Ally Wealth's tailored advice for Australian expats, the challenges and strategies of managing clients with international assets, and the company's approach to global financial planning and compliance. Joel Kerin LinkedIn: https://www.linkedin.com/in/joelkerin/ Ally Wealth Management Website: https://allywealth.com.au/ Help us make a difference for Australians in need today. Visit Future2 Foundation to find out more: https://ensombl.com/go/20251120 General Disclaimer – https://www.ensombl.com/disclaimer/

Ray Troll shares morning coffee in his Ketchikan lounge room with Dr. Karin Claeson, exploring fish evolution, anatomy, development, and variability across deep time.

Episode 191: In this episode of the Inform Performance Podcast, Andy McDonald is joined by Dr Fearghal Kerin. Fearghal is a chartered physiotherapist with extensive experience in elite sports. He has worked across Irish sports, including as Rehabilitation Physiotherapist at Leinster Rugby for nine seasons, before transitioning to Chelsea Football Club in the English Premier League, where he held the same position. At Chelsea, he worked with international athletes including Premier League, Champions League and World Cup winners. In this episode Andy and Fearghal discuss the management of T-Junction hamstring Injuries.  Topics Discussed: Evolving Perspectives on Strength and Injury Prevention   Understanding T-Junction Hamstring Injuries   Diagnostic Challenges and Testing for T-Junctions   Establishing a Competency-Based Pathway   Understanding Loading and Injury Prevention   Revising Traditional Approaches to Hamstring Injuries   The Importance of Execution in Rehabilitation   Exploring the Role of Ankle and Hip Mechanics   Identifying Contributing Factors to Hamstring Injuries   Innovations in Rotational Testing and Rehabilitation - Where you can find Fearghal: LinkedIn X (Twitter) Instagram -  Sponsors VALD Performance, makers of the Nordbord, Forceframe, ForeDecks and HumanTrak. VALD Performance systems are built with the high-performance practitioner in mind, translating traditionally lab-based technologies into engaging, quick, easy-to-use tools for daily testing, monitoring and training Hytro: The world's leading Blood Flow Restriction (BFR) wearable, designed to accelerate recovery and maximise athletic potential using Hytro BFR for Professional Sport.  -  Where to Find Us Keep up to date with everything that is going on with the podcast by following Inform Performance on: Instagram Twitter Our Website - Our Team Andy McDonald Ben Ashworth Alistair McKenzie Dylan Carmody Steve Barrett  Pete McKnight

Slišali ste odlomek iz četrtkovega podkasta Rast, v katerem smo gostili Lojzeta Kerina.

Slišali ste odlomek iz četrtkovega podkasta Rast, v katerem smo gostili Lojzeta Kerina.

Join us for a compelling conversation with Trish Kerin, an award-winning international expert in process safety leadership, as she explores the concept of weak signals—those subtle early warnings that often go unnoticed until it's too late. In this insightful episode, Trish introduces The Platypus Philosophy®, a powerful and memorable metaphor that provides a framework for identifying and managing weak signals in the workplace. She shares a practical action plan built around engaging acronyms and explains how to train our brains to see beyond the obvious to foster safer work environments. Trish also highlights the essential role of curiosity in leadership and teams, empowering organizations to spot these weak signals and take timely, proactive steps to mitigate risk. Tune in to discover how recognizing and acting on weak signals can lead to stronger safety outcomes and improved performance. Don't miss this thought-provoking episode! About the Guest: Trish Kerin is an award-winning international expert and keynote speaker on process safety leadership. A master storyteller and self-professed safety geek, she works with organisations globally to share and learn in process safety, leveraging her engineering, operational, and executive experience. She is a Chartered Engineer, registered Professional Process Safety Engineer, Fellow of IChemE and Engineers Australia, and a Senior Member of AIChE. Trish holds a Diploma in OHS, a Master of Leadership, and is a Graduate of the AICD. For more information: www.leadlikekerin.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Informacije o dogodkih po svetu redko pridejo do vseh ljudi. Vseeno smo izvedeli kaj se je zgodilo v Parizu, kaj se dogaja po svetu. So tudi dogodki, ki jih ne moremo zaslediti v medijih. Vedno znova je potrebno pomagati človeku, da bi svoje hrepenenje po sreči prav udejanjil v svojem življenju. Dogodki zadnjih let kažejo, koliko ljudem je to ukradeno ali celo uničeno. Ob beguncih smo postali prestrašeni, skušali smo se temu izogniti. Pri sprejemanje beguncev na obalah otoka Lampedusa v Sredozemlju je zdravnik Petro Bartolo naredil vse kar je lahko. Vsak je prinesel s seboj svojo zgodbo. Najbolj pretresljive so bile zgodbe otrok. Tihotapili so jih za prodajanja njihovih organov. Potem so jih odvrgli na smetišče. Veliko dogodkov niti ne pride v medije. Teh dogodkov ne vidimo in o njih ne slišimo. Vse to je življenje danes. Odprte človeške oči opazijo propadanje civilizacije, ki je storila veliko dobrega za vse človeštvo. Kaj se dogaja? Mislim, da nas pritegne govorjenje o pravici do sreče. Do nje skušamo priti preko raznih oglaševalcev, ki nam s svojimi izdelki zagotavljajo pravo pot k sreči. In mi temu verjamemo! TODA! Sreča sama po sebi ne obstaja. Vedno je povezana z ljudmi okoli nas. Zaprti v svoje lastne želje in trenutne občutke sreče, začnemo propadati. Nikakor ne moremo priti do obljubljene sreče in veselja. Zakaj nihče o tem ne govori? Zakaj nihče ne usmerja ljudi v pravo smer. NAPAKA! Veliko ljudi govori o svoji poti, o svojem zgrešenem pojmovanju življenja in o pravih vrednotah. Med njimi je uspešen mlad poslovnež Jean – Marc Potdevin, ki sam o sebi pravi, da je pri 40 letih imel vse kar si človek želi: imel je dobro službo, imel je dovolj denarja, imel ugled v družbi, privoščil si je lahko vse kar si je zaželel. Ob tem je prišel do spoznanja, da mu zavidanja vreden uspeh ni potešil globlje želje, želje po sreči. Spremenil je svoje življenje. Postal je svoboden, ker je imel pogum zapustiti lažno svobodo iz oseminšestdesetih let – pravzaprav suženjstva razpuščenih nagonov (tako sam pravi). Vedno znova potrebujemo spodbude, zglede, ki bi nas usmerjali v pravo smer. Vprašanje je ali vidimo te zglede? Polnost sreče ne najdemo v trenutkih veselja, polnost sreče najdemo v prizadevanju za druge, za srečo in veselje drugih. Potrebno je veliko odpovedovanja, premagovanja samega sebe. Na tej poti hitro omagamo, zato so potrebni ljudje, ki nas spodbujajo in nam stojijo ob strani. Vsak izmed nas lahko postane opora in zgled za druge. To je odločitev za življenje, za kulturo življenja, to je odločitev za srečo. Odločitev je naša!

Nigel is back again to discuss the business of farming, and mindset in particular. Expanding on our previous two podcasts with Nigel, he shares his approach to business, the evolution of his mindset and strategies for managing risk and climate variability. He also talks about the importance of continual learning and, as Nigel puts it, “buying brains”. In this episode, we discuss:✔ How to build a resilient farm business✔ What good leadership really looks like on-farm ✔ Why scaling up isn't always the answerIf you're looking to future-proof your business, manage labour better, and build systems that don't fall apart under pressure, tune in today. Head Shepherd is brought to you by neXtgen Agri International Limited. We help livestock farmers get the most out of the genetics they farm with. Get in touch with us if you would like to hear more about how we can help you do what you do best: info@nextgenagri.com.Thanks to our sponsors at MSD Animal Health and Allflex, and Heiniger Australia and New Zealand. Please consider them when making product choices, as they are instrumental in enabling us to bring you this podcast each week.Check out Heiniger's product range HERECheck out the MSD range HERECheck out Allflex products HERE

In this episode of The Egg Whisperer Show, I welcome Dr. Iris Kerin Orbuch, a renowned expert on endometriosis, to discuss the complexities and challenges of living with this disease. We explore how endometriosis affects fertility, the obstacles to early diagnosis, and the misconceptions that often delay proper treatment. Dr. Orbuch shares insights on the integrative approaches used in her practice, highlighting the importance of gut health in managing endometriosis. We also discuss the critical need for specialized surgical treatment and how endometriosis impacts overall health and well-being. Her holistic perspective, which combines surgical expertise with a deep understanding of the body's integrative systems, offers hope and healing to those affected by this often misunderstood condition. In This Episode, We Cover: Why endometriosis is so often misdiagnosed and how to advocate for proper care The difference between excision surgery and other surgical treatments The connection between gut health, inflammation, and endometriosis symptoms Why a multidisciplinary approach—including physical therapy, nutrition, and mindfulness—can make all the difference The biggest myths about endometriosis that can delay diagnosis and treatment Resources: Dr. Iris Kerin Orbuch's Website Follow Dr. Orbuch on Instagram Beating Endo: How to Reclaim Your Life from Endometriosis Read the full show notes on my website. IVF Class: Do you have questions about IVF? Click here to join me for The IVF Class. The next live class call is on Monday, April 21, 2025, at 4pm PST, where I'll explain IVF and Egg Freezing, and there will be time to ask your questions live on Zoom. Other ways to reach me: Visit my YouTube channel for more fertility tips! Subscribe to the newsletter to get updates. Join Egg Whisperer School. Request a Consultation with me. Dr. Aimee Eyvazzadeh is one of America's most well-known fertility doctors. Her success rate at baby-making gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org.  

Odpikajmo nasilje je kampanja RTV Slovenija, ki se bori proti medvrstniškemu nasilju. Njen zaščitni znak so štiri pike, ki pomenijo štiri zaveze proti nasilju nad vrstniki. Kampanja bo potekala od 8. do 22. marca, za vas pa pripravljamo več televizijskih in radijskih oddaj ter drugih vsebin na to temo, tako za otroke kot za odrasle. Gostja Svetovalnega servisa je bila predsednica Društva za nenasilno komunikacijo Katja Zabukovec Kerin. Pojasnila je:  kako medvrstniško nasilje prepoznamo,  kako naj ravnajo odrasli, ko opazijo, da otrok doživlja nasilje,  zakaj naj starši posredujejo pri medvrstniškem nasilju,  kako naj odrasli ravnajo, če otrok noče govoriti o tem, kaj doživlja,  kako naj ravnajo starši, če njihov otrok izvaja nasilje,  kakšno vlogo pri medvrstniškem nasilju imajo vrstniki, ki opazujejo nasilna dejanja. 

»Nimam časa!«. To sta dve besedi, ki se vedno znova ponavljata med ljudmi. Skoraj vse je do trenutka načrtovano. Vsaj bilo je tako. Tudi mednarodna pomoč ljudem v deželah, ki živijo v težjih življenjskih razmerah, je bila načrtovana. Določeni so bili datumi do kdaj mora biti projekt izpeljan. In seveda, kar je najbolj pomembno, videti je treba rezultate. Ob vsem se ne sme pozabiti na trajnost sprememb, ki jih bo prinesel določen projekt. Vse smo načrtovali. Najbolj in seveda najprej načrtujejo gospodarstveniki. Hočejo rezultat dela, ki ga načrtujejo. In rezultat več imeti jim je uspelo prenesti na ljudi po vsem svetu. Ljudje hitijo, da ne bi kaj zamudili. Marsikomu se je v teh mesecih utrnilo vprašanje: JE TO RES POTREBNO? In v ta točno načrtovan urnik pride nekaj, kar nihče ni predvideval. Čas se je ustavil! Naenkrat je dovolj časa. Kako pa ta čas uporabimo? Čas lahko uporabimo tudi za to, da pregledamo kaj se dogaja v našem življenju. Ne ustavljajmo se pri zunanjih dogodkih! Kaj se dogaja v nas? Kako sprejemam občutek nemoči? To so trenutki, ko preverim sam v sebi, kaj je v življenju pomembno, kaj pa je morda nepomembno. In ugotovili bomo, da v življenju ni pomembno samo tisto, kar imam. Veliko bolj pomembno je: kakšen sem v svoji notranjosti. Čas je, da ne poslušam tistega, kar mi drugi dopovedujejo. zdaj je čas, da odkrivam kje so temelji mojega življenja, kam je usmerjena pot mojega življenja. V roke lahko vzamem knjige, v katerih so drugačna razmišljanja, ki jih po navadi vidimo in poslušamo na televiziji, beremo v takšnih in drugačnih časopisih. So vrednote, ki se ne spreminjajo že tisočletja. Temelj naj bi bile kreposti, ki so neuničljive: RAZUMNOST, PRAVIČNOST, SRČNOST, ZMERNOST. To je tisto, kar spreminja družbo, če to verjamemo ali ne. To so temeljni kamni vsake civilizacije, ki spoštuje človekovo dostojanstvo. Odkrili bomo, da vse dobro nastaja počasi, ne čez noč. Nič velikega, dramatičnega se ne zgodi, če ne delam prav. Ob opazovanju ljudi, ki delajo slabo, človeka razjeda misel, zakaj nekateri ljudje uspevajo, čeprav so krenili na pot, ki uničuje življenje ljudi. V nas se pojavi nevoščljivost, morda tudi brezbrižnost. Že pred tisočletji je bilo zapisano: »Le kaj je človek v blaginji, če je brez modrosti, podoben je živali, ki pogine. (prim.: Ps 48,10-21) Življenje se ne ustavi, življenje gre vedno naprej. Bom del tega neustavljivega življenja? Bom znal dodajati nekaj dobrega in lepega življenju, ki ga živim z drugimi. NE ČAKAJ NA JUTRI – ZDAJ JE ČAS ZA TO!

Happy Mardi Gras everybody. Things are winding up or winding down to Fat Tuesday on March 4th 2025…Depending on how you look at it. And who better to help us find out all about the big fun here in the Big Rainy is Steve Kerin, keyboardist and co-founder of the Misty Krewe of Nimbus, our own Portland Mardi Gras Krewe, Steve Kerin. The Krewe is throwing their annual Mardi Gras Ball at the Wonder Ballroom on Saturday, March first and then on Mardi Gras day it'll be time for their big Parade. That's when the big bass drum leads the big parade Paul K Ward is producing today's episode, he's at the controls at his studioblue…one word all lower case and a big thank you to him for helping to pull the podcast out of hiatis hell while I recover. I'm at my desk in Northwest Portland, and Steve Kerin is at home in NE Portland. Steve, Hey now and Happy Mardi Gras!

Avenue United Captain Ronan Kerin After FAI Junior Cup Win Over Cockhill Celtic

Voordat je rode oortjes krijgt, we bedoelen een chip-triootje: ASML, ASMI en Besi. Die aandelen stijgen hard na goed nieuws van chipmaker TSMC. Vooral de winst valt op. Deze aflevering kijken we of de Nederlandse chipbedrijven dat kunstje ook kunnen flikken. De AEX-droom van Fastned spat uiteen. Het bedrijf wordt door beleggers aan de kant gezet. Fastned heeft last van de trage groei van elektrische auto's en moet daardoor ook het eigen groeitempo terugschakelen. Over de AEX gesproken, die gaat op de schop. Nu bestaat de index nog uit 25 namen, dat moeten er binnenkort 30 worden. Maar schiet je daar als belegger ook wat mee op? En een doorbraak voor Jeff Bezos: hij lanceert een 100 meter lange raket met zijn Blue Origin. Daarmee wordt hij een serieuze concurrent voor SpaceX, van Elon Musk. See omnystudio.com/listener for privacy information.

FlamesNation Barn Burner with Boomer, Pinder & WarrenerTIMESTAMPShttps://youtube.com/live/ElPZMO4lAAM- Pinder's Gone (2:00)- Flames Game-day (6:00)- Blackhawks Suck (7:30)- Kerin's Debut (8:00)- Yegor (11:00)- Road Win (15:00)- Pospisil Hit (17:00)- Brunt Joins (21:00)- Edge Interview (22:00 - 34:00)- Four Nations (37:00)- Future Projects (44:00)- Brunt Out (45:00)- Pinder Report (52:00)- BET365 (01:27:00)FLAMESNATION MERCHhttps://nationgear.ca/collections/flamesnationBARN BURNER CLIPShttps://www.youtube.com/playlist?list=PLj_bcGtvvo-cW2DHEDZ6dEO5ePDmlhZc9SHOUTOUT TO OUR SPONSORS!!

In this episode of the Pacey Performance Podcast, Rob is speaking to Bryan Heiderscheit, Fearghal Kerin and Emidio Pacecca. The topic of this conversation is all around MRI and its use in athlete performance profiling. MRI scans are usually thought of an expensive tool that is used when an athlete gets injured. But in this episode we break down those barriers and disciver how they can be used, through technology like Springbok Analytics, in other ways to improve performance and mitigate injury risk with healthy athletes. First we discuss MRI and what it actually is. Bryan gives us some great examples of where it can be used and why. Fearghal and Emidio then give us some amazing insights from the world of elite sport on how MRI scans are actually being used. But most importantly, they give us the real key information which is what we do with the information once we have it. If you're trying to reduce injury risk and optimise performance, check out this episode.

Endometriosis is an inflammatory disorder affecting many women, with symptoms ranging from painful periods to gastrointestinal issues and fatigue. In this episode, Dr. Iris Kerin Orbach explores the complexities of this condition, emphasizing the importance of surgical excision over ablation for better outcomes. She highlights the significant challenges endometriosis poses to fertility, impacting egg quality, sperm mobility, and embryo implantation.  Dr. Iris advocates for a comprehensive, integrative approach to treatment, addressing physical, emotional, and dietary factors to improve patients' quality of life. Discover how optimizing overall health through prehabilitation, acupuncture, nutrition, and stress-reducing techniques can enhance fertility treatment success and create a conducive environment for conception and pregnancy. Key takeaways: Endometriosis, an inflammatory disorder, causes symptoms like painful periods, gastrointestinal issues, and fatigue. Surgical excision is the gold standard treatment for endometriosis, offering better outcomes than ablation. Endometriosis significantly impacts fertility, affecting egg quality, sperm mobility, and embryo implantation. A comprehensive, integrative approach, including physical, emotional, and dietary factors, can improve patients' quality of life. Optimizing health through prehabilitation, acupuncture, nutrition, and stress-reduction techniques enhances fertility treatment success. Dr. Iris Kerin Orbuch Bio:  Dr. Iris Kerin Orbuch is a renowned endometriosis excision surgeon and author of the best-selling book "Beating Endo: How to Reclaim Your Life From Endometriosis." She features prominently in the film "BELOW THE BELT," executively produced by Hillary Rodham Clinton. Dr. Orbuch treats endometriosis as an inflammatory disease, emphasizing surgical excision. She integrates eastern and western medicine, working with a team of specialists to provide holistic care. Known for her compassionate and personalized approach, she is passionate about helping all patients, especially teens and adolescents, lead pain free lives. Dr. Orbuch serves on the AAGL Foundation Board, has held leadership roles in the AAGL, published extensively, and is part of the Society for Women's Health Research Endometriosis Working Group. She is also the Director at Advanced Gynecologic Laparoscopy Center in LA and NYC.    Where To Find Dr. Iris Kerin Orbuch:     Website: https://www.lagyndr.com/ Book “Beating Endo: How to Reclaim Your Life from Endometriosis”: https://www.amazon.com/Beating-Endo-Holistic-Treatment-Endometriosis/dp/0062861832  Instagram: https://www.instagram.com/dririskerinorbuch/ How to connect to Lorne Brown online and in person (Vancouver, BC)   Acubalance.ca book virtual or in person conscious work sessions with Dr. Lorne Brown  Lornebrown.com   Conscious hacks and tools to optimize your fertility by Dr. Lorne Brown: https://acubalance.ca/conscious-work/   Endometriosis Treatment at Acubalance: https://acubalance.ca/blog/endometriosis-awareness-month-10-tools-to-support-endometriosis/   Download a free copy of the Acubalance Fertility Diet & Recipes and a copy of the ebook 5 Ways to Maximize Your Chances of Getting Pregnant from Acubalance.ca   Connect with Lorne and the podcast on Instagram: @acubalancewellnesscentre @conscious_fertility_podcast @lorne_brown_official DISCLAIMER: By listening to this podcast, you agree not to use it as medical advice to treat any medical condition in either yourself or others. This podcast offers information to help the listener cooperate with physicians, mental health professionals or other healthcare providers in a mutual quest for optimal well-being. We advise listeners to carefully review and understand the ideas presented, and to consult your own physician for any medical issues that you may be having. Under no circumstances shall Acubalance, any guests or contributors to the Conscious Fertility podcast, or any employees, associates, or affiliates of Acubalance be responsible for damages arising from the use of the podcast.  

When you are in that terribly complicated time of making medical decisions around advanced cancer, what framework can you turn to? Oncologists are called upon to treat and offer options; patients hope to gain time if not be cured. What are the choices and the impact of those choices for advanced solid tumor cancers? What if I told you that two doctors have gathered the data to find out whether certain treatments extend life or not. Would you listen to that conversation to find out more? I would!

I'm sure you know how it feels when you meet someone new at an event and within a few minutes you feel you've found a kindred spirit? Someone who speaks your language. Well, that is how I felt when I met Kerin Rose… and it's not because Rose was my maiden name.  Kerin was a member of a metalsmithing community I belonged to on Etsy. I'm sure if you have listened to the podcast for anything length of time you have heard me talk about EtsyMetal and the positive impact it had on my success as a new business owner.  I've probably known Kerin for 20 years now, but we've never sat down and had a conversation together. We would mostly chat about the business of selling jewelry, in our Etsy group forum, or more recently through DM's. However, Kerin's jewelry and ceramic work resonated with me on soul level and I knew that we spoke the same language which is why I was over the moon when she agreed to have a conversation with me on Slowmade. I've personally known Kerin as a wonderful jewelry and clay artist, but I was really surprised to hear her art journey extended far beyond those lines. I think you'll find her story surprising as well. From Kerin's website... "I am an artist  and  beauty hunter..... mostly, I am a believer in 'kinship magic'. It means that a person's personal energy can travel through an object.  How  do we connect more deeply to the natural world?  To each other?  To beauty? To the darker side of human existence? What do the spaces between us mean , and what are they actually made of?  Life is beautiful, and it's also hard...we are asked to hold both of those things  in our hands and heart at the same time. Sometimes, you need a tangible object, a ritual, a symbol of being human. That is where I come in." Website: www.kerinrose.com Instagram: @kerinrose If this podcast means something to you and you would like to support it, please take a a moment to give it a few kinds word with a written review on your favorite podcast listening platform. This helps me share the podcast with others. You can also share a favorite episode or consider joining our Slowmade Podcast Patreon community. You support literally makes this podcast possible. Thank you so much! You can follow along or reach out to Christine on Instagram: ⁠⁠⁠@christinemighion⁠⁠⁠ or ⁠⁠⁠@slowmadepodcast⁠⁠⁠ or you can send her an email at: info@christinemighion.com

In this episode of the Pacey Performance Podcast, Fearghal Kerin, Rehabilitation Physiotherapist, Chelsea Football Club, discusses the growing prevalence of T-junction hamstring injuries and the importance of location-specific rehabilitation strategies. Fearghal outlines his background, highlighting his PhD focused on hamstring injuries and his work in professional sports, including football and rugby. He emphasizes the evolving role of strength and conditioning coaches in injury rehabilitation and the need for a nuanced approach to managing hamstring injuries based on their anatomical location. Hamstring injuries are classified into sprint-type and stretch-type, with the T-junction—a confluence of the long and short head of the biceps femoris—being particularly susceptible to injury. This area is complex due to its dual force vectors, dual nerve supply, and bi-articular function, making it challenging to rehabilitate. Fearghal discusses the necessity of considering biomechanical positions and sport-specific actions when diagnosing and treating hamstring injuries. He highlights that traditional low-level resistance exercises may not effectively prepare athletes, advocating for high-intensity conditioning contractions instead. He stresses the importance of eliminating MRI signs before returning to play, as unresolved edema and tension can increase the risk of reinjury. Specific tissue loading and exercise selection are crucial, with a focus on exercises that respect the injury's anatomical structure. Research indicates that T-junction injuries, though complex, do not necessarily lead to worse outcomes than other hamstring injuries if managed correctly. This podcast concludes with a call for more research and personalized rehabilitation strategies to optimize recovery and prevent recurrence. Main talking points: Implement location-specific rehab for hamstring injuries Focus on high-intensity conditioning contractions Diagnose hamstring injuries using biomechanical analysis Tailor rehab exercises to injury's anatomical location Eliminate MRI signs before return to play Use sport-specific actions in rehabilitation plans Avoid low-level resistance exercises for preparation Address neuromuscular factors in hamstring rehab Consider trunk rotation in injury assessments Control unanticipated movements during rehab Ensure sequential imaging for accurate injury management Extend rehab for field sport athletes as needed.

Krampitz, Karsten www.deutschlandfunk.de, Tag für Tag

“Let's empower patients to help themselves. That's going to be the best way to affect change.” - Iris Kerin Orbuch, MDEndometriosis is a condition with neurologic, immune-inflammatory, and autoimmune components. While surgical excision is the cornerstone of treatment and necessary for most people to recover fully, we need a multidisciplinary approach to address endo's massive impact on the body comprehensively.As practitioners, one of the most important aspects to address is the sensation of safety in the body. To do that, we have to work both with physical tools, like optimizing nutrition, and with trauma and the mental/emotional impact of chronic illness. A part of your work is also to practice your own self-regulation so that being in your presence will help your clients regulate themselves.Today, I'm so excited to be joined by a dear friend of mine and one of the top endometriosis surgeons in the world, Iris Kerin Orbuch, MD. For years, Dr. Iris has been outspoken about the need for a multidisciplinary approach to treating endometriosis, and she continues to challenge her colleagues to rethink some of the earlier ways of addressing the condition. Dr. Iris uses an integrative approach to help her patients heal and get on the road to recovery.In this conversation, Dr. Iris and I discuss the complexities of endometriosis, the need for an integrative approach to treatment, Dr. Iris' journey with endometriosis, her advocacy for patients, the challenges of diagnosis, why we need to address the whole body, mind-body medicine, and more.Enjoy the episode, and let's innovate and integrate together!Learn more or watch the video version of this conversation at https://integrativewomenshealthinstitute.com/getting-better-outcomes-with-endometriosis-excision-surgery-with-dr-iris-orbuch/.Connect with me and access our entire platform at IntegrativeWomensHealthInstitute.com (https://integrativewomenshealthinstitute.com/). Find and follow us @integrativewomenshealth on YouTube (https://www.youtube.com/@integrativewomenshealth) and Instagram (https://www.instagram.com/integrativewomenshealth/).

Host Jo Reed and AudioFile's Emily Connelly discuss how narrator André Santana skillfully performs Chuck Tingle's thrilling Hollywood horror novel. Screenwriter Misha Byrne has just received an ultimatum from the studio executives — their algorithm says to kill off his beloved queer TV characters, or else. Misha refuses, and Santana captures Misha's initial angry exasperation, then his escalating terror as he suddenly faces deadly characters from his horror films. Scripts of certain mysterious scenes are performed by a full cast of authors. It's both a spine-tingling horror story and a moving exploration of queer identity, humanity, and storytelling.  Read the full review of the audiobook on AudioFile's website. Published by Macmillan Audio. Discover thousands of audiobook reviews and more at AudioFile's website.    Support for AudioFile's Behind the Mic comes from Dreamscape Media, featuring their new audiobook Rifts and Refrains. Follow Amara Johnson's journey through music, mystery, and romance, available exclusively on Dreamscape First. Don't miss out on this captivating tale… please visit Dreamscape to learn more and start listening! Learn more about your ad choices. Visit megaphone.fm/adchoices

Mikael and Lachlan Kerin answer listener questions.                IN THIS EPISODE YOU'LL LEARN ABOUT: -Training with a focus on longevity and health -Differences in power output on flats vs. uphill (and what you can do about it) -Training strategies for athletes with a "diesel" phenotype -The tradeoff between stroke (and stride) rate and stroke length  -Should you ride at a lower cadence to "save" your cardiovascular system for the run?  SHOWNOTES: https://scientifictriathlon.com/tts438/ SCIENTIFIC TRIATHLON AND THAT TRIATHLON SHOW WEBPAGE: www.scientifictriathlon.com/podcast/ SPONSORS: Precision Fuel & Hydration help athletes personalise their hydration and fueling strategies for training and racing. Use the free Fuel & Hydration Planner to get personalised plan for your carbohydrate, sodium and fluid intake in your next event. That Triathlon Show listeners get 15% off their first order of fuel and electrolyte products. Simply use this link and the discount will be auto-applied at the checkout.   ZEN8 - The ZEN8 Indoor Swim Trainer allows you to improve technique, power, and swim training consistency. You can target specific aspects of your stroke, like catch and pull-through, work on core activation and body position, and make sure you stay consistent in your swim training even when you don't have time to go to the pool. Try the Zen8 risk-free for 30 days, and get 20% off your first order on zen8swimtrainer.com/tts. LINKS AND RESOURCES: Lachie's coaching profile page and Instagram Road gradient and cycling power: An observational study in male professional cyclists - Valenzuela et al. 2022 That Triathlon Show guests Olympic Podium picks for Paris 2024 RATE AND REVIEW: If you enjoy the show, please help me out by subscribing, rating and reviewing: www.scientifictriathlon.com/rate/ CONTACT: Want to send feedback, questions or just chat? Email me at mikael@scientifictriathlon.com or connect on Instagram, Facebook, or Twitter.  

Send us a Text Message.Nigel Kerin returns to the podcast this week to discuss profit drivers, decision rules, staying curious and the importance of science and technology in farming.Nigel has a great way of thinking about the business of farming and no decision is made without analysing it first. Nigel uses a triangular model to help him make these hard decisions.“Down one side of the triangle, you've got business growth. Down the bottom, you've got cash flow. And up the other side of the triangle, you've got people, infrastructure, and I've now added technology into it.”Nigel runs each of his decisions through this model, “For me to go ahead and go down a particular path of doing something, [I ask] does it fit in with those three sides of that triangle?” This opens up a series of questions that help him look at the decision from multiple perspectives. “Does it increase growth? Does it increase cash? Have I got the infrastructure and people and the technology to do this at scale? And when I look down each side of that triangle, where's the weakest link in our business at the moment? Is it actually growth? Is it cash flow? Do we have a people problem at the moment, which may be a lack of staff? Do we have an infrastructure problem? That can be wire and mortar, stockyards, cattle yards, sheep yards and laneway systems. Or do we have a lack of technology?”Nigel puts great emphasis on staying curious. “You're constantly opening your mind up to shortcuts and those 1% changes are what drive a business.”Not every idea he has makes it past the triangle stage, but that doesn't stop him thinking about new ideas and concepts. “It's a massive profit driver in your business, no matter what business you're in, whether you're in a news agency or pharmacy or butcher shop or farming - whatever. If you're constantly in a curious mindset, you've got your mind and your peripheral vision open to new ideas all the time.”Nigel explains that these ideas come about, not from staying on the farm 365 days a year, but from getting out and learning from more informed people: consultants, courses, open days or events such as Lambex or Beef. “What football side wins a grand final without a coach? What tennis player at Wimbledon wins without a coach?” asks Nigel. “I don't have to know everything and I don't have to be that incredibly clever, just as long as I'm bringing those people into our business to help us question how we make decisions, help us make decisions and sometimes hold our hands whilst we're making those decisions.”As with Nigel's previous podcast, ‘Turning Grass into Money', this episode is worth sharing amongst staff, friends and family. There are many gems, from mindset changes to practical on-farm examples of success. Head Shepherd is brought to you by neXtgen Agri International Limited, we help livestock farmers get the most out of the genetics they farm with. Get in touch with us if you would like to hear more about how we can help you do what you do best - info@nextgenagri.com.Thanks to our sponsors at MSD Animal Health and Allflex, and Heiniger Australia and New Zealand.These companies are leaders in their respective fields and it is a privilege to have them supporting the Head Shepherd Podcast. Please consider them when making product choices, as they are instrumental in enabling us to bring you this podcast each week.Check out Heiniger's product range HERECheck out the MSD range HERECheck out Allflex products HERE

Avenue United Captain Ronan Kerin After Ennis Carpets Clare Cup Final Win

Liz Kerin returns to talk about her latest novel, First Light, the sequel to Night's Edge. Together with Trevor, she talks about how the book approaches complex issues of guilt and grief, about how it handles its revenge arc, and about the way the book reflects on empathy and radicalization over trauma. You can find more from Liz Kerin at her website, lizkerin.com, and you can get your copy of First Light from Tor Nightfire wherever you buy your books. Become a member at https://plus.acast.com/s/sley-house-publishing-presents-litbits. https://plus.acast.com/s/sley-house-publishing-presents-litbits. Hosted on Acast. See acast.com/privacy for more information.

EPISODE 57: Author and screenwriter Liz Kerin returns to UFDP with updates and to share the reality of how the development process of turning her Night's Edge duology into a TV series concluded.

EPISODE 56: Liz Kerin, playwright, screenwriter and author of vampire duology Night's Edge and First Light, told UFDP all about her writing process and the development process of adapting her own novel into a TV series during last year's writers strike.

Hark, Constructs! We hope you enjoy the third episode in our series of Bonus Episodes we're calling, “Tomb Talks”, where we invite some of our favorite authors and artists to our table to discuss their work and the works that inspire them as well as the various types of nerdy media we consume. This interview features Liz Kerin, author of The Phantom Forest (2019) and Night's Edge! The sequel, First Light, comes out tomorrow! We hope you enjoy the conversation! Very Respectfully, Nick & Emily Liz Kerin's ⁠Website⁠ and ⁠Socials⁠ ! Follow The Unlocked Tomb Podcast ⁠⁠⁠Here⁠⁠⁠! Podcast Artwork by: ⁠⁠⁠Marceline_Art⁠⁠⁠ Featuring Original Music by: - ⁠⁠⁠Chelsea Lankes⁠⁠⁠ - Ghost© (Remix by ⁠⁠⁠Dance with the Dead⁠⁠⁠ (Permission for use granted by the artist)

FIRST LIGHT is coming out on April 23rd! It's the much-anticipated sequel to Kerin's debut novel NIGHT'S EDGE. First thing's first: Order FIRST LIGHT right now! And if you're new to Liz, you can also order NIGHT'S EDGE at the same time, on my Liz Kerin list on BookshopNow that that's taken care of. If you haven't done so, go back and listen to my interview with Liz for NIGHT'S EDGE. I don't know if you know, but vampires are back, in a big way. Leading the charge is Liz Kerin, with her breakout duology about a young woman named Mia, who is navigating a world where vampires are among us, but they're not welcome. And oh yeah her mom is one, but nobody knows, so she has to be mom's source of food or she'll go away. NIGHT'S EDGE established Mia and her struggles with her family secret, and FIRST LIGHT takes her out into the world. All Mia wants is to be a normal person, but she's haunted by her a past she can't let go of, and she wants answers. I really loved these books, and in this episode I got to dig into some of the themes of FIRST LIGHT with Liz. We talked about love, forgiveness, rebellion, and a lot more. And I say “really cool” in this episode enough times that, looking back, I'm a little embarrassed. I need to be better with my choice of words.Since it's a duology, I'll share links to both of the episodes on YouTube, for you visual types: NIGHT'S EDGEFIRST LIGHT Get full access to The ARC Party at www.thearcparty.com/subscribe

In this episode, host Clarice is joined by Kerin Browning to discuss the complex world of land use and planning. They delve into the complexities of zoning regulations, the impact on property development, and the importance of understanding local zoning ordinances when investing in real estate ventures. Kerin provides valuable insights and practical strategies to navigate the zoning process as a developer or investor. With a focus on demystifying the topic, this episode serves as a valuable resource for those seeking to understand the fundamentals of land use and planning. Whether you're a seasoned investor or a newcomer to the field, this episode offers a comprehensive overview and practical advice to help you confidently navigate the world of zoning and land use.

I was joined by author Liz Kerin to talk about her duology, Night's Edge and First Light through music!   Night's Edge playlist First Light playlist

Avenue United Captain Ronan Kerin On MFA Quarter Final

In this episode of Environmentally Speaking host Clarice welcomes Kerin Browning to the team and they engage in a nuanced discussion about a recent court decision concerning land use and zoning issues. The conversation delves into the legal complexities surrounding notice requirements, the concept of hardship in the context of zoning variances, and the essential deliberative process for municipal boards. By examining a specific case, the episode provides valuable insights into the intricate legal framework of land use decisions, shedding light on the significance of thorough legal considerations in zoning matters. Join Clarice and Kerin as they analyze the legal nuances and practical implications of this intriguing zoning case.

All week Kerin and Delaney have been teasing this amazing flavor combination, so as the coup de grâce for a Friday we finally get to taste the Espresso Martini!

In today's enlightening episode on the Women's Vibrancy Code, we're honored to be joined by Dr. Iris Kerin Orbuch, a leading figure in the world of endometriosis and the acclaimed author of "Beating Endo: How to Reclaim Your Life from Endometriosis." Dr. Orbuch has dedicated nearly two decades to the field, making invaluable strides in both women's health policy and education. In this episode we put a focus on endometriosis, a widespread yet frequently overlooked condition that deeply affects many women. Together we get into the intricate symptoms, understand why it often remains undiagnosed, and explore the ways women can begin to reclaim their lives. Dr. Orbuch doesn't just emphasize surgical treatments. She beautifully merges eastern and western medical traditions, collaborating extensively with a diverse range of health experts, and holds a special dedication to supporting teens and adolescents. Highlighting her career are her pivotal roles with organizations like the AAGL Foundation and the SWHR Endometriosis Working Group, along with noteworthy mentions in premier publications. These achievements not only showcase her expertise but also her unwavering commitment to enhancing women's health through compassion, knowledge, and collaboration. Together we covered the following: Endometriosis Explored: Grasp the complexities of this condition that affects numerous women. Symptoms & Frequent Oversights: Understand the diverse manifestations of endometriosis and its common misdiagnoses. Inflammation Insights: Learn about endometriosis as an inflammatory condition. Diagnosis & Treatment: Discuss the significance of accurate diagnosis and the vital role of surgical excision. Holistic Healing: Appreciate Dr. Orbuch's innovative combination of eastern and western medical practices. Team-Based Approach to Recovery: Discover the importance of collaborating across medical disciplines. This episode is more than just information—it's an insight into a condition that affects millions. With Dr. Orbuch's holistic approach and deep expertise, you're sure to gain both understanding and inspiration. Make sure to tune in to dive into a topic vital to women's health and leave empowered. Follow along with Dr. Iris Kerin Orbuch: Website | Instagram | Beating Endo: How to Reclaim Your Life from Endometriosis Apply today for a free consult with Maraya to receive a personalized plan: Click here to apply Subscribe To The Women's Vibrancy Code: Women's Health And Wellness with Maraya Brown: Apple Podcast | YouTube | Spotify Connect With The Show: Facebook Page | Linkedin | Website | Tiktok | Facebook Group Make A Connection Call With Maraya Brown: Click here to book About Maraya Brown: Maraya is a Yale and Functional Medicine Trained Women's Health And Wellness Expert CNM, MSN with her undergraduate degree in marketing. She helps women feel turned on by their life, their lover and themselves.  Her work online brings her 21 years of experience supporting women together in one place to co-create deep transformation, energy and passion. Maraya is the founder of this Podcast and does a great deal of work with women to expand their energy, hormones, libido, confidence and much much more. DISCLAIMER: The podcasts available on this website have been produced for informational, educational and entertainment purposes only. Listeners should take care to avoid program content which may not be suited to them. The contents of this podcast do not constitute medical or professional advice, No person listening to and/or viewing any podcast from this website should act or refrain from acting on the basis of the content of a podcast without first seeking appropriate professional advice and/or counseling, nor shall the information be used as a substitute for professional advice and/or counseling. The Women's Vibrancy Code Podcast expressly disclaims any and all liability relating to any actions taken or not taken based on any or all contents of this site.  The Women's Vibrancy Code: Women's Health And Wellness w/ Maraya Brown

Scientific Triathlon coaches Lachlan Kerin and Mikael Eriksson discuss all things coaching and coach-athlete relationship and things athletes should know about coaching and coaches.          IN THIS EPISODE YOU'LL LEARN ABOUT: -Who should consider getting a coach (and who should not)? -What are the benefits of coaching?  -What should you expect from a coach?  -What does a good coach-athlete relationship look like?  -Local or remote coaching?  -How to find the right coach for you -Pricing considerations -The time-course of a coach-athlete relationship -Myths and misconceptions about coaching -The future of coaching and the AI coach   SHOWNOTES: https://scientifictriathlon.com/tts406/   SCIENTIFIC TRIATHLON AND THAT TRIATHLON SHOW WEBPAGE: www.scientifictriathlon.com/podcast/   SPONSORS: Precision Fuel & Hydration help athletes perform at their best through their online tools, patented Sweat Test and range of electrolytes and fueling products. Use the free Fuel & Hydration Planner and receive a personalised plan for your carbohydrate, sodium and fluid intake. If you want further help, book a free 20-minute video consultation to chat through your plan. Listen out for the code in today's show to get 15% off your first order of PF&H electrolytes and fueling products. If you missed the code, just email hello@pfandh.com.   ZEN8 - The ZEN8 Indoor Swim Trainer is a unique Dryland Swim Trainer that allows you to improve technique, power, and swim training consistency. With the trainer you can do specific power and technique work, including working on your catch and core activation, and it helps you stay consistent even if you don't have much time to train. You can try the Zen8 risk-free for up to 30 days, and you can get 20% off your first order on zen8swimtrainer.com/tts.   LINKS AND RESOURCES: Lachie's coaching bio Scientific Triathlon coaching Training Camp Mallorca 2024   RATE AND REVIEW: If you enjoy the show, please help me out by subscribing, rating and reviewing: www.scientifictriathlon.com/rate/   CONTACT: Want to send feedback, questions or just chat? Email me at mikael@scientifictriathlon.com or connect on Instagram, Facebook, or Twitter.

Brea and Mallory tick off a box on the 2023 Reading Glasses Challenge: listen to background music or sounds while you read. Plus, an interview with Liz Kerin and recommendation honkers! Email us at readingglassespodcast at gmail dot com!Reading Glasses MerchRecommendations StoreSponsors -Dipseawww.dipseastories.com/GLASSESLinks -Reading Glasses Facebook GroupReading Glasses Goodreads GroupAmazon Wish ListNewsletterLibro.fmTo join our Slack channel, email us proof of your Reading-Glasses-supporting Maximum Fun membership!Books Around the CornerLiz KerinBooks Mentioned - Raw Dog by Jamie LoftusEmily Wilde's Encyclopaedia of Faeries by Heather FawcettNestlings by Nat CassidyI Can't Save You by Anthony Chin-QueeThe Insatiable Volt Sisters by Rachel Eve MoultonSenlin Ascends by Josiah BancroftThe Bone Shard Daughter by Andrea Stewart

Kristen Barnett and Trevor Kerin are the Co-Founders of Culinary Creators Worldwide, a new agency focused on omnichannel activations for the next generation of culinary influencers. In this episode we'll chat about the opportunity for influencers to work with brands, ghost kitchens, and tech firms to create tangible consumer experiences, the potential for grocers and restauranteurs to tap into such talent, and the key to successful partnerships in the space. Watch on YouTube Join the HNGRY Newsletter

Professor Michael Kerin, Director of Cancer Centre in Saolta and Professor of Surgery at University of Galway, joins Ryan to talk about his life and work in the west of Ireland.

In this episode, Kerin shares her inspiring background and triumph over eating disorders, challenging deeply ingrained belief systems formed at a young age.  Explore the power of nourishing your body with foods that make you feel good and delve into the impact of weight on your dating life. Discover the mindset of a confident woman who knows her worth and unravel the toxic patterns that hinder meaningful connections. Gain insights into cultivating a balanced approach to working out, eating, and lifestyle choices, embracing both feminine and masculine energies. Reflect on the significance of setting boundaries around health, wellness, food, and dating, and get ready to gain clarity on your desires within relationships.  Kerin is an Executive Life Coach with a mission to redefine standards in health, body, mind and spirit to truly live in a happy body and lead a successful life. Specializing in the development of emotional balance, confidence, mindset management, and intuitive weight loss, Kerin specializes in the release of trauma from the cellular body and the repatterning of the thoughts and emotions that hold us back from showing up as the person we desire to be.  Join us for an empowering conversation that will ignite personal growth, inspire transformation, and lead to fulfilling connections.   We get into:  [0:00] Intro [1:00] Kerin's background and experience with eating disorders [5:10] The belief system people develop at a young age [8:00] Eating foods that make you feel good [10:45] How weight affects your dating life [12:10] Being a woman who knows her worth [16:00] Toxic dating patterns [17:50] Unraveling your mindset around working out, eating and lifestyle choices [19:45] The balance between feminine and masculine energetics [23:30] Do you need to sleep with someone to know if you like them or not? [25:30] Boundaries around health, wellness, food and dating [32:55] Getting clear about what you desire in a relationship   Connect with Kerin Instagram: https://instagram.com/kerin.eilis Facebook: https://www.facebook.com/groups/789941495857983/?ref=share_group_link  Freebie: https://view.flodesk.com/pages/62750363ec93244248595fa6    Connect with us! Instagram: http://www.instagram.com/confessionsofafuckaholic  Email us: sexandbacon1@yahoo.com   

In this episode, Trevor interviews Liz Kerin, author of Night's Edge from Tor Nightfire (out June 20, 2023). They talk about her upcoming novel and its sequel, vampires and trauma, dog naming conventions, and having to grow up fast under unfair circumstances.Please note that this episode does contain very light spoilers about Night's Edge and a brief preview for the sequel, First Light.You can find more information about Liz's novel at tornightfire.com, and follow her on Instagram @lizkerin or her website, lizkerin.com. Become a member at https://plus.acast.com/s/sley-house-publishing-presents-litbits. https://plus.acast.com/s/sley-house-publishing-presents-litbits. Hosted on Acast. See acast.com/privacy for more information.

Pre-order NIGHT'S EDGE and FIRST LIGHT on my bookshop LIZ KERIN LISTLiz Kerin was nice enough to join me on the podcast recently, to talk about her upcoming coming of age vampire book NIGHT'S EDGE. It's a very personal story about a young woman and her mother, and the sacrifices that they make to keep a dark and dangerous secret. And the best news is that Liz is not only already working on the sequel book, but there's also a TV adaptation of NIGHT'S EDGE in the works, with Liz involved as a writer! So join us as we talk about vampires, family secrets, growing up, mother/daughter relationships, and a lot more. It's a great conversation, and hopefully it inspires you to support Liz!As mentioned in the episode, if you want to do something to support the WGA members who are on strike, here is the website to the Entertainment Community Fund. If you're looking for somewhere to give, this is a great start!YouTube video: Get full access to The ARC Party at www.thearcparty.com/subscribe

Week three of MCRch, we discuss My Chemical Romance's seriously epic "Helena." We also discuss the latest news in punk and address some serious drama in the complaint department. And Georgia drops some MCR tidbits throughout. Our guest this week is Kerin Cunningham. She shows up around 1:51:40. Follow Kerin on Twitter: https://twitter.com/KerinCunningham Support the pod on Patreon: https://www.patreon.com/155pod